The Future of Weight Management: How Genetics and the Microbiome Influence Long-Term Success For millions struggling with obesity, the arrival of glucagon-like peptide-1 (GLP-1) receptor agonists, such as semaglutide and …
HBA1C
-
-
The Link Between Maternal Health During Pregnancy and Long-Term Cardiovascular Outcomes in Offspring As a physician, I often emphasize that prenatal care is about more than just the immediate health …
-
We need to produce article about “Why heart risk is hard to predict in type 1 diabetes”. Use verified info from reputable sources. Must produce HTML article with headings, paragraphs, …
-
Technology
Dapiglutide Trial: Dual Gut Hormone Agonist Shows Promise But Fails to Beat Placebo for Obesity
Dapiglutide: Novel GLP-1/GLP-2 Agonist Shows Promise in Early Obesity Trials A new drug, dapiglutide, combining GLP-1 and GLP-2 receptor activation, is being investigated as a potential treatment for obesity. Early …
-
GLP-1s and Tirzepatide: Weighing Benefits Against Emerging Risks Widely used medications like GLP-1 receptor agonists (GLP-1RAs) and tirzepatide have become popular for weight loss and diabetes management. While offering significant …
-
PFAS Exposure May Reduce Benefits of Weight Loss Surgery in Teens A new USC study shows teens with higher blood levels of per- and polyfluoroalkyl substances (PFAS) measured before bariatric …